Based on Phase 2 clinical trial data, retatrutide is administered as a once-weekly subcutaneous injection, consistent with other long-acting incretin-based therapies such as semaglutide and tirzepatide
A licensed healthcare provider will ultimately determine if semaglutide is appropriate for you
This represents a massive increase in bioavailability, potentially elevating topical applications to levels approaching injectable delivery
Yes, due to the additives included in the prefilled syringes that allow for extended dating, patients may experience different side effect profiles on the prefilled syringes compared to the vials
It might get worse when ibuprofen upsets the stomach and tirzepatide slows the process of emptying it
A medical professional can evaluate individual health situations, discuss potential risks and benefits, and advise on established, evidence-based treatments